Botulinum Toxin (Botox) for TMD

Type: drug

Status: FDA Approved (for other indications, widely used off-label for TMD)

Developer: Allergan (now AbbVie)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026